Document ID: chunk:federal_register_of_legislation:F2022L00259:clause:1_1:p3
Version: federal_register_of_legislation:F2022L00259
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 3/4)
Character Range: 21073–26290

Military Rehabilitation and Compensation Act 2004.
                               paraganglioma means a neoplasm of chromaffin tissue which is associated with excess secretion of catecholamines, and is located in an extra-adrenal sympathetic ganglion.
                               phaeochromocytoma means a neoplasm of chromaffin tissue which is associated with excess secretion of catecholamines, and is located in the adrenal medulla.
                               primary hyperaldosteronism means a syndrome associated with excess production of the major adrenal mineralocorticoid, aldosterone.
                                  relevant service means:
         (a)          eligible war service (other than operational service) under the VEA;
         (b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
         (c)          peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                               Specified List 1 of drugs means:
         (a)           abiraterone;
         (b)           androgen receptor blockers including flutamide, bicalutamide, darolutamide and enzalutamide;
         (c)          androgens including the anabolic steroids stanozolol and nandrolone;
         (d)          antiretroviral therapy;
         (e)          clozapine;
         (f)            combined hormonal contraceptives;
         (g)          cyclizine;
         (h)          disulfiram;
         (i)            gonadotrophin releasing hormone agonists including goserelin and leuprorelin;
         (j)            gonadotrophin releasing hormone antagonists including degarelix;
         (k)          leflunomide;
         (l)            lithium;
         (m)        metoclopramide;
         (n)          mineralocorticoids including fludrocortisone;
         (o)          non-steroidal anti-inflammatory drugs excluding aspirin;
         (p)          olanzapine;
         (q)          psychostimulants including amphetamines and methylphenidate;
         (r)           sibutramine;
         (s)           serotonin-norepinephrine re-uptake inhibitors including venlafaxine, duloxetine, desvenlafaxine and levomilnacipran;
         (t)            sympathomimetics including mirabegron, nasal decongestants, oral decongestants and 10% phenylephrine eye drops;
         (u)          systemic anti-fungal agents including itraconazole and posaconazole;
         (v)          thioridazine;
         (w)        tricyclic antidepressants;
         (x)          tropisetron; or
         (y)          tumour necrosis factor inhibitors.
         Note 1: Examples of nasal decongestants include oxymetazoline, phenylephrine, tramazoline and xylometazoline.
Note 2: Examples of oral decongestants include phenylephrine and pseudoephedrine.
                               Specified List 2 of drugs means:
         (a)          alkylating agents including cyclophosphamide;
         (b)          bromocriptine mesylate;
         (c)          cisplatin;
         (d)          cyclosporine A;
         (e)          docetaxel;
         (f)           erythropoietins including epoetin alfa, epoetin beta, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta;
         (g)          ibrutinib;
         (h)          mammalian target of rapamycin inhibitors including sirolimus and everolimus;
         (i)            monoamine oxidase inhibitors including phenelzine, tranylcypromine and selegiline;
         (j)            physostigmine;
         (k)          proteasome inhibitors including bortezomib and carfilzomib;
         (l)            tacrolimus; or
         (m)        vascular endothelial growth factor (VEGF) inhibitors.
        Note: Vascular endothelial growth factor (VEGF) inhibitors include monoclonal antibodies, such as bevacizumab and ramucirumab; the fusion molecule aflibercept; and tyrosine kinase inhibitors, such as cabozantinib, sorafenib, sunitinib and vandetanib.
                               Specified List 3 of drugs means:
         (a)          amprenavir;
         (b)          atazanavir;
         (c)          boceprevir;
         (d)          clarithromycin;
         (e)          darunavir;
         (f)           delavirdine;
         (g)          erythromycin;
         (h)          fosamprenavir;
         (i)            indinavir;
         (j)            isoniazid;
         (k)          itraconazole;
         (l)            ketoconazole;
         (m)        lopinavir;
         (n)          nelfinavir;
         (o)          posaconazole;
         (p)          ritonavir;
         (q)          saquinavir;
         (r)           telaprevir;
         (s)           telithromycin;
         (t)            tipranavir; or
         (u)          voriconazole.
                               specified list of endocrine disorders means:
         (a)          a renin-secreting neoplasm;
         (b)          acromegaly;
         (c)          Cushing syndrome;
         (d)          hyperparathyroidism;
         (e)          hyperthyroidism, including goitre or Graves disease that has resulted in hyperthyroidism;
         (f)           hypothyroidism, including